Trial site
Fundacion CITA Alzheimer
- 4running trials
- 4closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease8 trials
- Mild cognitive impairment3 trials
- Down syndrome2 trials
- Epilepsy1 trial
- Phase
- Phase 35 trials
- Phase 22 trials
- Phase 11 trial
- Status
- Completed4 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Eisai Inc.2 trials
- F. Hoffmann-La Roche AG1 trial
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1 trial
- Glaxosmithkline Research & Development Limited1 trial
- Inmune Bio, Inc.1 trial
- and 2 more
Running trials
Not yet recruiting
A study to learn about the effects of Trontinemab in participants at risk for Alzheimer‘s disease
Recruiting
LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome
Active, not recruiting
Active, not recruiting
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease2 recruiting
- Down syndrome1 recruiting
- Epilepsy1 recruiting
Closed trials
Terminated
Completed
EFFICACY AND SAFETY OF GSK4527226 [AL101] IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE
Completed
A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Site data: EU CTIS (euclinicaltrials.eu)Updated 13 Nov 2026